Aggravation of hypertriglyceridemia and acute pancreatitis in a bipolar patient treated with quetiapine
- PMID: 24719155
- PMCID: PMC3990081
- DOI: 10.3349/ymj.2014.55.3.831
Aggravation of hypertriglyceridemia and acute pancreatitis in a bipolar patient treated with quetiapine
Abstract
Pancreatitis is a very rare adverse effect of quetiapine treatment, with only 5 cases of quetiapine-associated pancreatitis reported in the English literature to date. Herein, we report one patient who developed severe hypertriglyceridemia (>1000 mg/dL) after quetiapine administration, resulting in acute pancreatitis. An analysis of the underlying pathogenic mechanisms and a review of relevant literature are also presented. Clinicians should be aware of the potentially life-threatening metabolic disturbances and/or pancreatitis associated with quetiapine therapy.
Keywords: Quetiapine; hypertriglyceridemia; pancreatitis.
Conflict of interest statement
The authors have no financial conflicts of interest.
References
-
- Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet. 2008;371:143–152. - PubMed
-
- Cappell MS. Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy. Med Clin North Am. 2008;92:889–923. - PubMed
-
- Balani AR, Grendell JH. Drug-induced pancreatitis : incidence, management and prevention. Drug Saf. 2008;31:823–837. - PubMed
-
- Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143–155. - PubMed
-
- Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5:648–661. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical